MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/gps.5839

Медицинская библиотека · International journal of geriatric psychiatry · 2022

Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment.

van de Beek Marleen, van Unnik Annemartijn, van Steenoven Inger, van der Zande Jessica, Barkhof Frederik, Teunissen Charlotte E, van der Flier Wiesje, Lemstra Afina W

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND

OBJECTIVES

Dementia with Lewy Bodies (DLB) is a heterogeneous disease, with variable signs and symptoms across multiple domains. We aimed to identify associations with rate of change in cognition, everyday functioning (IADL) and quality of life (QoL).

METHODS

We included 121 DLB patients (69 ± 6 yrs, 14%F, MMSE: 25 ± 3) in our prospective cohort (follow-up 2 ± 1 yrs). We described progression of symptoms and cognitive decline over time. Mixed models were used to investigate whether changes in symptoms were associated to changes in IADL (FAQ), QoL (QoL-AD) and caregiver burden (ZBI). Last, we investigated whether baseline symptoms and biomarkers predicted decline in cognition (MMSE), IADL (FAQ) and QoL (QoL-AD).

RESULTS

Parkinsonism and RBD were most frequently present early in the disease course, while hallucinations were more likely to develop in a later stage. MMSE (annual change β ± SE = -2.06 ± 0.23), QoL-AD (-1.03 ± 0.20), and FAQ (3.04 ± 0.30) declined over time. Increasing severity of clinical symptoms was associated to increases in FAQ, QoL-AD and caregiver burden. Baseline clinical symptoms were not predictive for decline in these outcomes. By contrast, AD co-pathology (CSF pTau/Aβ42 ratio) was associated to steeper decline in MMSE (-1.23 ± 0.54). Medial temporal atrophy (-0.81 ± 0.26) and global cortical atrophy (-0.73 ± 0.36) predisposed for decline in QoL-AD.

CONCLUSIONS

Our findings imply that underlying disease processes, rather than clinical symptomatology aid in predicting decline. These findings are relevant for treatment strategies and the development of DLB specific outcome measures.

Для цитирования: van de Beek Marleen, van Unnik Annemartijn, van Steenoven Inger, van der Zande Jessica, Barkhof Frederik, Teunissen Charlotte E, van der Flier Wiesje, Lemstra Afina W. Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment.. International journal of geriatric psychiatry. 2022. DOI: 10.1002/gps.5839.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.